Abstract
LINC01410 is a recently identified long non-coding RNA located on chromosome 9 that plays a multifaceted role in human diseases. Its dysregulation is closely associated with tumor initiation, progression, and therapeutic response. LINC01410 promotes oncogenesis by modulating key signaling pathways, such as PTEN/AKT, Notch, ErbB, and NF-κB, interacting with non-coding RNA networks, and influencing the expression of proteins involved in tumor biology. Beyond these roles, it contributes to cancer metabolism by regulating glycolysis, lipid droplet accumulation, and exosome-mediated intercellular communication, thereby shaping the tumor microenvironment and enhancing malignancy. Intriguingly, LINC01410 exhibits opposite expression patterns in non-malignant conditions such as preeclampsia and diabetic nephropathy, highlighting its context-dependent biological function. Collectively, these findings position LINC01410 as a pivotal regulator linking protein expression, metabolism, and intercellular signaling, underscoring its potential as a biomarker and therapeutic target in oncology.